Endocardial voltage mapping (LA-LVS ≥2 cm2 at 0.5 mV) predicted lower freedom from arrhythmia at 12 months (43% vs. 81%, P=0.009), whereas LA-LGE-MRI extent did not (50% vs. 67%, P=0.338).
Observational (n=37)
How do LA-LGE-MRI methods compare with endocardial voltage mapping for detecting atrial cardiomyopathy and predicting arrhythmia recurrence in patients with persistent AF undergoing PVI?
Endocardial voltage mapping correlates better with atrial activation time and is a stronger predictor of arrhythmia recurrence after PVI than LA-LGE-MRI methods, which show large discrepancies in detecting atrial cardiomyopathy.
Absolute Event Rate: 43% vs 81%
p-value: p=0.009
AIMS: Atrial cardiomyopathy (ACM) is associated with increased arrhythmia recurrence rates after pulmonary vein isolation (PVI). We compare the most common left atrial (LA) late gadolinium enhancement magnetic resonance imaging (LGE-MRI)-methods Utah-method and image intensity ratio (IIR)-methods and endocardial voltage mapping for ACM-detection and outcome prediction after PVI for atrial fibrillation (AF). METHODS AND RESULTS: In this prospective observational study, 37 ablation-naive patients (66 ± 9 years, 84% male) with persistent AF underwent LA-LGE-MRI and high-definition voltage and activation mapping (2129 ± 484 sites) in sinus rhythm prior to PVI. The MRI-post-processing-analyses were performed by two independent expert laboratories. Arrhythmia recurrence was recorded within 12 months following PVI. The global ACM-extent was highly variable: median LA low-voltage substrate (LA-LVS) was 12.9% at <1.0 mV and 2.7% at <0.5 mV; median LA-LGE-extent using the Utah-method was 18.3% and 0.03-93.1% using the IIR-methods. The LA activation time was significantly correlated with LA-LVS (r = 0.76 at <0.5 mV and r = 0.82 at <1.0 mV, both P < 0.0001), but not with LA-LGE-extent. The highest regional matching between LA-LVS <0.5 mV and LA-LGE was found for the anterior wall in 57% of patients using the Utah-method and in 59% using IIR 1.20. The corresponding values for the posterior wall were 19% and 38%, respectively. Arrhythmia recurrence occurred in 15(41%) patients. Freedom from arrhythmia was significantly lower in those with LA-LVS ≥2 cm2 at 0.5 mV but not in those with LGE ≥20% (Utah-stages III and IV): 43% vs. 81%, P = 0.009 and 50% vs. 67%, P = 0.338, respectively. CONCLUSION: Comparison of the most common LA-LGE-MRI methods and endocardial voltage mapping revealed large discrepancies in global and regional ACM-extent.
Eichenlaub et al. (Tue,) conducted a observational in persistent atrial fibrillation (n=37). LA-LGE-MRI (Utah and IIR methods) and endocardial voltage mapping was evaluated on Freedom from arrhythmia at 12 months (LA-LVS ≥2 cm2 vs <2 cm2) (p=0.009). Endocardial voltage mapping (LA-LVS ≥2 cm2 at 0.5 mV) predicted lower freedom from arrhythmia at 12 months (43% vs. 81%, P=0.009), whereas LA-LGE-MRI extent did not (50% vs. 67%, P=0.338).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: